Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers

Journal of Clinical Anesthesia

Volumn 23, Issue 3, 2011, Pages 218-223

  Frölich, Michael A ^a   Arabshahi, Alireza ^b   Katholi, Charles ^c   Prasain, Jeevan ^b   Barnes, Stephen ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Dexmedetomidine; Hemodynamics; Midazolam; Propofol; Sedation, intravenous

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; PLACEBO; PROPOFOL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BREATHING RATE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HEART HEMODYNAMICS; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS REGIONAL ANESTHESIA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PATIENT CARE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; DEXMEDETOMIDINE; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; PROPOFOL; PROSPECTIVE STUDIES; RESPIRATION; SINGLE-BLIND METHOD;

EID: 79956018416     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2010.09.006     Document Type: Article

References (21)

1. DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge Survey. Natl Health Stat Report 2008(5):1-20.
2. Chang C, Uchiyama A, Ma L, Mashimo T, Fujino Y. A comparison of the effects on respiratory carbon dioxide response, arterial blood pressure, and heart rate of dexmedetomidine, propofol, and midazolam in sevoflurane- anesthetized rabbits. Anesth Analg 2009;109:84-9.
3. Heard C, Burrows F, Johnson K, Joshi P, Houck J, Lerman J. A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging. Anesth Analg 2008;107:1832-9.
4. Phan H, Nahata MC. Clinical uses of dexmedetomidine in pediatric patients. Paediatr Drugs 2008;10:49-69.
5. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005;94:821-4. (Pubitemid 40754000)
6. Shafer S. Stanpump, Version 1998 Edition, Open TCI, 1998, pp TCI program. (Available online at opentci.org).
7. Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991;67:41-8.
8. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993;78:821-8. (Pubitemid 23141354)
9. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35. (Pubitemid 14089351)
10. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51. (Pubitemid 20319177)
11. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr AC 1974;19:716-23.
12. Mizrak A, Koruk S, Ganidagli S, Bulut M, Oner U. Premedication with dexmedetomidine and midazolam attenuates agitation after electro-convulsive therapy. J Anesth 2009;23:6-10.
13. Ruokonen E, Parviainen I, Jakob SM, et al. "Dexmedetomidine for Continuous Sedation" Investigators. Dexmedetomidine versus propofol/ midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009;35:282-90.
14. Munro HM, Tirotta CF, Felix DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Paediatr Anaesth 2007;17:109-12. (Pubitemid 46089374)
15. O'Daniel TG, Shanahan PT. Dexmedetomidine: a new alpha-agonist anesthetic agent for facial rejuvenation surgery. Aesthet Surg J 2006;26:35-40. (Pubitemid 43264386)
16. Bekker AY, Basile J, Gold M, et al. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol 2004;16:126-35. (Pubitemid 39090033)
17. Mason KP, Zurakowski D, Zgleszewski SE, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18:403-11. (Pubitemid 351490487)
18. Barakat AR, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia 2007;62:661-6. (Pubitemid 46929958)
19. Liu SH, Wei W, Ding GN, Ke JD, Hong FX, Tian M. Relationship between depth of anesthesia and effect-site concentration of propofol during induction with the target-controlled infusion technique in elderly patients. Chin Med J (Engl) 2009;122:935-40.
20. Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997;86:836-47. (Pubitemid 27174724)
21. Bajpai L, Varshney M, Seubert CN, et al. Mass spectral fragmentation of the intravenous anesthetic propofol and structurally related phenols. J Am Soc Mass Spectrom 2005;16:814-24. (Pubitemid 40725157)